In the given study, we confirmed that the combination of tested molecules, meaning simultaneous targeting of cancer cells and KP enzyme, exerts a stronger antitumor response toward colon cancer xenografts than any of the used compounds alone. Here, NPPA is linked to malignant colon neoplasm.